Lansheng New York will provide international trade services for high-end medical device manufacturers in the U.S., and mid to low-ranged Chinese medical device manufacturers. The services include but are not limited to market intelligence reports, policy and regulation interpretation, public relations and product launching.
Lansheng New York will continue to expand Shanghai Lansheng’s U.S. partnership in the medical device industry. In addition, Lansheng New York will proactively look for opportunities to open channels for China based low to mid-ranged medical device products. For representing products in two markets, commission will be Lansheng New York’s major component of revenue.
Lansheng New York will initiate its business with international trade of U.S. made dietary supplement products to China. The potential for the China health products market is huge—both in terms of sales and healthcare cost savings. Currently, China ranks fourth in sales ($15.8 billion), only behind the United States, Japan, and Europe, according to USCHPA reports. Chinese customers value quality and clinical test results very much, and thus welcome U.S. products.
Copyright © 2020 Lansheng New York - All Rights Reserved.